Bevacizumab (Avastin) for the treatment of ocular disease.
Jan 01 2023
PubMed ID: 19422965 Author(s): Gunther JB, Altaweel MM. Bevacizumab (Avastin) for the treatment of ocular disease. Surv Ophthalmol. 2009 May-Jun;54(3):372-400. doi: 10.1016/j.survophthal.2009.02.004. Review. PMID 19422965 Journal: Survey Of Ophthalmology, Volume 54, Issue 3, 2009 The…
Read MoreAssociation of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trial.
Jan 01 2023
PubMed ID: 20706173 Author(s): Danis RP, Scott IU, Qin H, Altaweel MM, Bressler NM, Bressler SB, Browning DJ, Kollman C; Diabetic Retinopathy Clinical Research Network. Association of fluorescein angiographic features with visual acuity and with…
Read MoreResponse to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration.
Jan 01 2023
PubMed ID: 25230402 Author(s): Eadie JA, Gottlieb JL, Ip MS, Blodi BA, Danis RP, Chandra SR, Nork TM, Altaweel MM, Stern-Hogan BS. Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab…
Read MoreVILLA
Oct 07 2022
To evaluate safety and tolerability of the Port Delivery System (PDS) in patients with neovascular age-related macular degeneration (nAMD).
Read MoreReservoir Technique: A Novel Method for Pressure-Controlled Silicone Oil Infusion Using the Constellation Vitrectomy System.
Jun 01 2022
PubMed ID: 30681642 Author(s): Boeke PS, Altaweel MM. Reservoir Technique: A novel method for Pressure-Controlled Silicone Oil Infusion using the Constellation Vitrectomy System. Retina. 2022 Jun 1;42(6):1211-1213. doi: 10.1097/IAE.0000000000002458. PMID 30681642 Journal: Retina (Philadelphia, Pa.),…
Read MoreManagement of Iris Retraction Syndrome with Heterochromia and Retinal Detachment.
Sep 01 2021
PubMed ID: 34720982 Author(s): Goebel C, Crabtree GS, Altaweel MM. Management of Iris Retraction Syndrome with Heterochromia and Retinal Detachment. Case Rep Ophthalmol. 2021 Sep 23;12(3):809-815. doi: 10.1159/000519148. eCollection 2021 Sep-Dec. PMID 34720982 Journal: Case…
Read MoreVisual Acuity Outcome over Time in Non-Infectious Uveitis.
Aug 18 2021
PubMed ID: 31821051 Author(s): Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger…
Read MoreManagement of Retinal Detachment Associated with Morning Glory Disc Syndrome.
May 01 2021
PubMed ID: 34177542 Author(s): Etheridge T, Oakey Z, Altaweel MM. Management of Retinal Detachment Associated with Morning Glory Disc Syndrome. Case Rep Ophthalmol. 2021 May 25;12(2):457-463. doi: 10.1159/000516205. eCollection 2021 May-Aug. PMID 34177542 Journal: Case…
Read MoreSeven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.
May 01 2021
PubMed ID: 32918964 Author(s): Tomkins-Netzer O, Lightman SL, Burke AE, Sugar EA, Lim LL, Jaffe GJ, Altaweel MM, Kempen JH, Holbrook JT, Jabs DA; Multicenter Steroid Treatment Trial and Follow-up Study Research Group. Seven-Year Outcomes…
Read More